Chris Krawtschuk is the Global CFO of Jubilant Pharma. Chris has over 25 years of progressive experience in finance, corporate and business unit controllership, Big 4 audit, M&A, divestitures, and strategic alliances/joint ventures. Previously, Chris was the CFO of MorphoSys US, VP Global Lead Business Unit Controller at Pfizer and was a Managing Director in PwC’s Capital Markets and Accounting Advisory practice.
Chris received his BS in Accounting from William Paterson University. Chris is licensed as a CPA and has authored the AICPA practice aid for IPR&D in asset acquisitions and business combinations.